My feeling is the board are rapt with those clinical results about to be released to the European conference ....wanted to give its two key men a big pat on back with some options.....reading between the lines ...if anyone knows the value of viralytics it is scientific officer shafren .....offering him shares at 58.5 is only a pat on the back if the board thinks sp likely to rise - for example with some clinical results - agree very positive step
- Forums
- ASX - By Stock
- VLA
- Ann: Director and Management Options for Viralytics Leadership
Ann: Director and Management Options for Viralytics Leadership, page-3
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online